Bausch Health Companies Inc
BHCStock
$4.93−22.25%52W
Market Cap$2.50B
P/E11.31x
Div yield—
Beta1.28
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-43.15%
Price vs S&P 500 (4W)1.34%
VGM Score56.98
Market Capitalization$2.50B
P/E Ratio (Annual)11.31x
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
2.44
2.44
2.44
2.38
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BHCBausch Health Companies Inc | B | C | D | $4.93 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Bausch Health Companies is a diversified global pharmaceutical and medical device company focused on specialty care markets including gastroenterology, hepatology, neurology, and dermatology. Revenue is driven by its portfolio of branded products across Bausch + Lomb (eye care, largest segment), Salix (gastroenterology), Solta Medical (aesthetics), and other diversified products.